🚀 VC round data is live in beta, check it out!
- Public Comps
- AddLife
AddLife Valuation Multiples
Discover revenue and EBITDA valuation multiples for AddLife and similar public comparables like Tecan Group, MicroPort Scientific, Bausch Health, Mehow Innovative and more.
AddLife Overview
About AddLife
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals and laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.
Founded
1906
HQ

Employees
2.3K
Website
Financials (LTM)
EV
$3B
AddLife Financials
AddLife reported last 12-month revenue of $1B and EBITDA of $193M.
In the same LTM period, AddLife generated $446M in gross profit, $193M in EBITDA, and $62M in net income.
Revenue (LTM)
AddLife P&L
In the most recent fiscal year, AddLife reported revenue of $1B and EBITDA of $195M.
AddLife expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $446M | XXX | $434M | XXX | XXX | XXX |
| Gross Margin | 38% | XXX | 37% | XXX | XXX | XXX |
| EBITDA | $193M | XXX | $195M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $62M | XXX | $62M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| Net Debt | — | — | $377M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
AddLife Stock Performance
AddLife has current market cap of $2B, and enterprise value of $3B.
Market Cap Evolution
AddLife's stock price is $18.23.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $2B | 0.3% | XXX | XXX | XXX | $0.51 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAddLife Valuation Multiples
AddLife trades at 2.3x EV/Revenue multiple, and 13.7x EV/EBITDA.
EV / Revenue (LTM)
AddLife Financial Valuation Multiples
As of April 20, 2026, AddLife has market cap of $2B and EV of $3B.
Equity research analysts estimate AddLife's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
AddLife has a P/E ratio of 35.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 2.3x | XXX | 2.3x | XXX | XXX | XXX |
| EV/EBITDA | 13.7x | XXX | 13.6x | XXX | XXX | XXX |
| EV/EBIT | 25.1x | XXX | 24.7x | XXX | XXX | XXX |
| EV/Gross Profit | 5.9x | XXX | 6.1x | XXX | XXX | XXX |
| P/E | 35.9x | XXX | 35.6x | XXX | XXX | XXX |
| EV/FCF | 26.8x | XXX | 21.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified AddLife Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


AddLife Margins & Growth Rates
AddLife's revenue in the last 12 month grew by 4%.
AddLife's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.
AddLife's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
AddLife's rule of X is 26% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
AddLife Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | 1% | XXX | (2%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 20% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 26% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 24% | XXX | 24% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 6% | XXX | 6% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1% | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 30% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
AddLife Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| AddLife | XXX | XXX | XXX | XXX | XXX | XXX |
| Tecan Group | XXX | XXX | XXX | XXX | XXX | XXX |
| MicroPort Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| Bausch Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Mehow Innovative | XXX | XXX | XXX | XXX | XXX | XXX |
| Sinbon Electronics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AddLife M&A Activity
AddLife acquired XXX companies to date.
Last acquisition by AddLife was on XXXXXXXX, XXXXX. AddLife acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by AddLife
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAddLife Investment Activity
AddLife invested in XXX companies to date.
AddLife made its latest investment on XXXXXXXX, XXXXX. AddLife invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by AddLife
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout AddLife
| When was AddLife founded? | AddLife was founded in 1906. |
| Where is AddLife headquartered? | AddLife is headquartered in Sweden. |
| How many employees does AddLife have? | As of today, AddLife has over 2K employees. |
| Who is the CEO of AddLife? | AddLife's CEO is Fredrik Dalborg. |
| Is AddLife publicly listed? | Yes, AddLife is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of AddLife? | AddLife trades under ALIF B ticker. |
| When did AddLife go public? | AddLife went public in 2016. |
| Who are competitors of AddLife? | AddLife main competitors are Tecan Group, MicroPort Scientific, Bausch Health, Mehow Innovative. |
| What is the current market cap of AddLife? | AddLife's current market cap is $2B. |
| What is the current revenue of AddLife? | AddLife's last 12 months revenue is $1B. |
| What is the current revenue growth of AddLife? | AddLife revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of AddLife? | Current revenue multiple of AddLife is 2.3x. |
| Is AddLife profitable? | Yes, AddLife is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of AddLife? | AddLife's last 12 months EBITDA is $193M. |
| What is AddLife's EBITDA margin? | AddLife's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of AddLife? | Current EBITDA multiple of AddLife is 13.7x. |
| What is the current FCF of AddLife? | AddLife's last 12 months FCF is $99M. |
| What is AddLife's FCF margin? | AddLife's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of AddLife? | Current FCF multiple of AddLife is 26.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.